Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review
Luca Potestio,* Fabrizio Martora,* Sara Cacciapuoti, Matteo Megna, Alessia Villani, Angelo Ruggiero Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy*These authors contributed equally to this workCorresponden...
Saved in:
Main Authors: | Potestio L (Author), Martora F (Author), Cacciapuoti S (Author), Megna M (Author), Villani A (Author), Ruggiero A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter]
by: Potestio L, et al.
Published: (2024) -
Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines
by: Francesco Drago, MD, et al.
Published: (2022) -
Vaccine-induced pityriasis rosea and pityriasis rosea-like Eruptions: A review of literature and a case report of COVID-19 vaccine-induced pityriasis rosea
by: Eman Almukhadeb, et al.
Published: (2022) -
Pityriasis rosea and pityriasis rosea-like eruption: The distinction is relevant for diagnostic and prognostic reasons
by: Giulia Ciccarese, et al.
Published: (2024) -
Pityriasis rosea-like drug eruption secondary to deucravacitinib
by: Nisal Punchihewa, MD, et al.
Published: (2024)